alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 61, Number 84 (Tuesday, April 30, 1996)]
[Notices]
[Page 19048]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10662]



-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric Administration
[I.D. 042296A]


Mid-Atlantic Fishery Management Council; Meetings

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Notice of public meetings.

-----------------------------------------------------------------------

SUMMARY: The Mid-Atlantic Fishery Management Council and its Black Sea 
Bass Advisors, Habitat Committee, Demersal Species Committee (with 
Atlantic States Marine Fisheries Commission (ASMFC) Summer Flounder 
Board) and the Surfclam and Ocean Quahog Committee will hold public 
meetings.

DATES: The meetings will be held on May 14-16, 1996. See SUPPLEMENTARY 
INFORMATION for specific dates and times.

ADDRESSES: The meetings will be held at the Doubletree Inn (at 
airport), 4101 Island Avenue, Philadelphia, PA; telephone: 1-800-222-
TREE.
    Council address: Mid-Atlantic Fishery Management Council, 300 S. 
New Street, Dover, DE 19901; telephone: 302-674-2331.

FOR FURTHER INFORMATION CONTACT: David R. Keifer, Executive Director, 
Mid-Atlantic Fishery Management Council; telephone: 302-674-2331.

SUPPLEMENTARY INFORMATION:
    May 14
    1:00 p.m. - 3:00 p.m., the Black Sea Bass Advisors will meet.
    3:00 p.m. - 5:00 p.m., the Habitat Committee will meet.
    May 15
    8:00 a.m. - 12:00 p.m., the Demersal Species Committee will meet as 
Committee of the Whole (with ASMFC Summer Flounder Board).
    1:00 p.m. - 3:00 p.m., the Council will meet.
    3:00 p.m. - 5:00 p.m., the Surfclam and Ocean Quahog Committee will 
meet.
    May 16
    8:00 a.m. - approximately 1:00 p.m., the Council will meet.
    The purpose of these meetings is to review comments for the Black 
Sea Bass Fishery Management Plan (FMP) and discuss possible revisions 
to the hearing draft, the Mud Dump Draft Environmental Impact 
Statement, and review comments and possible adoption of Amendment 9 to 
the Surfclam and Ocean Quahog FMP.

Special Accommodations

    These meetings are physically accessible to people with 
disabilities. Requests for sign language interpretation or other 
auxiliary aids should be directed to Joanna Davis (see ADDRESSES) at 
least 5 days prior to the meeting dates.

    Dated: April 23, 1996.
Richard W. Surdi,
Acting Director, Office of Fisheries Conservation and Management, 
National Marine Fisheries Service
[FR Doc. 96-10662 Filed 4-29-96; 8:45 am]
BILLING CODE 3510-22-F
EXHIBIT 12.2

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


























                                                                             159


<PAGE>




    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of IMA Exploration Inc. (the "Company") on
Form 20-F for the period ending Decmeber 31, 2002, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, William Lee, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


/s/  WILLIAM LEE
--------------------------------------
William Lee,
Chief Financial Officer







                                                                             160
### Michigan Supreme Court Lansing, Michigan

Robert P. Young, Jr.,
Chief Justice

Michael F. Cavanag h Marilyn Kell y Stephen J. Markma n Diane M. Hathawa y Mary Beth Kell y Brian K. Zahra,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk September 6, 2011

y0829 

# Order

September 6, 2011

142645

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 142645 COA: 297681 Wayne CC: 07-020145-FC LARRY THOMAS SANDERS, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the applicati on for leave to appeal the December 28, 2010 order of the Court of Appeals is considered , and it is DENIED, because the defendant has

failed to meet the burden of establishi ng entitlement to relief under MCR 6.508(D).
[Federal Register Volume 61, Number 90 (Wednesday, May 8, 1996)]
[Notices]
[Page 20790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11445]



-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE
Forest Service


Western Washington Cascades Province Interagency Executive 
Committee (PIEC) Advisory Committee; Meeting

AGENCY: Forest Service, USDA.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Western Washington Cascades PIEC Advisory Committee will 
meet on May 28, 1996 at the Mount Baker-Snoqualmie National Forest 
Headquarters, 21905 64th Avenue West, in Mountlake Terrace, Washington. 
The meeting will begin at 9 a.m. and continue until about 4 p.m. Agenda 
items to be covered include: (1) Continuation of discussion of the 
possibilities, pros, cons, and probable ramifications (including legal 
and administrative requirements) of changing the original designations, 
under the Northwest Forest Plan, of the Skagit and Green River basins 
from ``non-key'' to ``key'' watersheds; (2) Access and Travel 
Management subcommittee report and discussion; (3) update on status of 
release of 318 timber sales under Section 2001 of Public Law 104-19 
(Rescission Bill); (4) information briefing on Washington Department of 
Fish and Wildlife's Salmon Habitat Enhancement and Restoration (SHEAR) 
program; (5) other topics as appropriate; and, (6) open public forum. 
All Western Washington Cascades Province Advisory Committee meetings 
are open to the public. Interested citizens are encouraged to attend.

FOR FURTHER INFORMATION CONTACT:
Direct questions regarding this meeting to Chris Hansen-Murray, 
Province Liaison, USDA, Mt. Baker-Snoqualmie National Forest, 21905 
64th Avenue West, Mountlake Terrace, Washington 98043, 206-744-3276.

    Dated: May 2, 1996.
Daniel T. Harkenrider,
Acting Forest Supervisor.
[FR Doc. 96-11445 Filed 5-7-96; 8:45 am]
BILLING CODE 3410-11-M
EXHIBIT 31.1

                                 CERTIFICATIONS


I, F. William Capp, certify that:

1.       I have reviewed this annual report on Form 10-K of Beacon Power
         Corporation;

2.       Based on my knowledge, this report does not contain any untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances under which
         such statements were made, not misleading with respect to the period
         covered by this report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this report, fairly present in all material
         respects the financial condition, results of operations and cash flows
         of the registrant as of, and for, the periods presented in this report;

4.       The registrant's other certifying officer and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
         registrant and have:

         (a) Designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within those entities, particularly during the period in
         which this report is being prepared;

         (b) Evaluated the effectiveness of the registrant's disclosure controls
         and procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

         (c) Disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting; and

5.       The registrant's other certifying officer and I have disclosed, based
         on our most recent evaluation of internal control over financial
         reporting, to the registrant's auditors and the audit committee of the
         registrant's board of directors:

         (a) All significant deficiencies and material weaknesses in the design
         or operation of internal control over financial reporting which are
         reasonably likely to adversely affect the registrant's ability to
         record, process, summarize and report financial information; and

         (b) Any fraud, whether or not material, that involves management or
         other employees who have a significant role in the registrant's
         internal control over financial reporting.



         March 31, 2005


         /s/ F. William Capp
         F. William Capp
         Chief Executive Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5861 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 5861

  To extend reemployment services and eligibility assessments to all 
      claimants for unemployment benefits, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            October 2, 2023

   Mr. LaHood (for himself and Mr. Davis of Illinois) introduced the 
 following bill; which was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To extend reemployment services and eligibility assessments to all 
      claimants for unemployment benefits, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Building on Reemployment 
Improvements to Deliver Good Employment for Workers Act'' or the 
``BRIDGE for Workers Act''.

SEC. 2. ELIGIBILITY FOR REEMPLOYMENT SERVICES.

    Section 306(a) of the Social Security Act (42 U.S.C. 506(a)) is 
amended--
            (1) by striking ``individuals referred to reemployment 
        services as described in section 303(j)'' and inserting 
        ``claimants for unemployment compensation, including claimants 
        referred to reemployment services as described in section 
        303(j),''; and
            (2) by striking ``such individuals'' and inserting ``such 
        claimants''.
                                 <all>
```
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Michael F. Cavanagh

Marilyn Kelly

Stephen J. Markman

Diane M. Hathaway

Mary Beth Kelly

Brian K. Zahra, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 _________________________________________

 Clerk

September 4, 2012

t0827

Order 

September 4, 2012

145204

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 145204

COA: 299654

Wayne CC: 09-018124-FC

CONRAD ROBERT SCHULTZ,

Defendant-Appellant. 

_________________________________________/

On order of the Court, the application for leave to appeal the April 10, 2012 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court.
EXHIBIT 31.2

                                 CERTIFICATIONS


I, James M. Spiezio, certify that:

1.   I  have   reviewed  this  annual  report  on  Form  10-K/A  of Beacon Power
     Corporation;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material  fact or omit to state a  material  fact  necessary  to make the
     statements made, in light of the circumstances  under which such statements
     were made,  not  misleading  with  respect  to the  period  covered by this
     report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in  this  report,  fairly  present  in all  material
     respects the financial  condition,  results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The  registrant's  other  certifying  officer  and  I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     (a)  Designed  such  disclosure  controls  and  procedures,  or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure that material information relating to the registrant,  including its
     consolidated  subsidiaries,  is made  known to us by  others  within  those
     entities,  particularly  during the  period in which  this  report is being
     prepared;

     (b) Evaluated the effectiveness of the registrant's disclosure controls and
     procedures  and  presented  in  this  report  our  conclusions   about  the
     effectiveness of the disclosure  controls and procedures,  as of the end of
     the period covered by this report based on such evaluation; and

     (c)  Disclosed  in this  report  any  change in the  registrant's  internal
     control over financial reporting that occurred during the registrant's most
     recent fiscal quarter that has materially affected, or is reasonably likely
     to materially  affect,  the  registrant's  internal  control over financial
     reporting; and

5.   The registrant's  other certifying  officer and I have disclosed,  based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors:

     (a) All significant  deficiencies and material  weaknesses in the design or
     operation of internal control over financial reporting which are reasonably
     likely to adversely  affect the  registrant's  ability to record,  process,
     summarize and report financial information; and

     (b) Any fraud,  whether or not material,  that involves management or other
     employees who have a significant role in the registrant's  internal control
     over financial reporting.


                                May 13, 2004


                               /s/ James M. Spiezio
                               James M. Spiezio
                               Chief Financial Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5818 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 5818

 To amend title XVIII of the Social Security Act to expand coverage of 
  the in-home administration of intravenous immune globulin under the 
                           Medicare program.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 28, 2023

 Mr. Smith of Nebraska (for himself and Mr. Garamendi) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
 To amend title XVIII of the Social Security Act to expand coverage of 
  the in-home administration of intravenous immune globulin under the 
                           Medicare program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medicare IVIG Access Enhancement Act 
of 2023''.

SEC. 2. EXPANDING COVERAGE OF THE IN-HOME ADMINISTRATION OF INTRAVENOUS 
              IMMUNE GLOBULIN UNDER THE MEDICARE PROGRAM.

    (a) In General.--Section 1861 of the Social Security Act (42 U.S.C. 
1395x) is amended--
            (1) in subsection (s)(2)(Z), by inserting ``(and, beginning 
        January 1, 2026, for the treatment of chronic inflammatory 
        demyelinating polyneuropathy and multifocal motor neuropathy)'' 
        after ``primary immune deficiency diseases''; and
            (2) in subsection (zz), by inserting ``(or, beginning 
        January 1, 2026, with diagnosed chronic inflammatory 
        demyelinating polyneuropathy and multifocal motor neuropathy)'' 
        after ``primary immune deficiency disease''.
    (b) Authority for Variance in Payments.--Section 1842(o)(8) of the 
Social Security Act (42 U.S.C. 1395u(o)(8)) is amended by inserting 
``and may vary depending on whether such administration is related to 
treatment of a primary immune deficiency disease or the treatment of 
chronic inflammatory demyelinating polyneuropathy or multifocal motor 
neuropathy (as determined appropriate by the Secretary through notice 
and comment rulemaking)'' after ``of 2012''.
                                 <all>
```
**EXHIBIT31.2**

**CERTIFICATIONS**

I, James M.Spiezio, certify that:

1.                 I have reviewedthis annual report on Form 10-K of Beacon Power Corporation;

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                 The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

(a)          Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

(b)         Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(c)          Disclosed in this reportany change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

5.                 The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors:

(a)          All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

(b)         Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.

| March 29, 2007      |
|--------------------------|
| /s/ JAMES M. SPIEZIO     |   |
| James M. Spiezio         |
| Chief Financial  Officer |

 

----
[Federal Register Volume 61, Number 92 (Friday, May 10, 1996)]
[Notices]
[Page 21499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11665]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration; 
Norac Co., Inc.

    By Notice dated October 16, 1995, and published in the Federal 
Register on October 23, 1995, (60 FR 54387), Norac Company, Inc., 405 
S. Motor Avenue, Azusa, California 91702, made application to the Drug 
Enforcement Administration to be registered as a bulk manufacturer of 
tetrahydrocannabinols (7370), a basic class of controlled substance 
listed in Schedule I.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Norac Company, Inc. to manufacture 
the listed controlled substance is consistent with the public interest 
at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: April 12, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-11665 Filed 5-9-96; 8:45 am]
BILLING CODE 4410-09-M
<PAGE>
                                                                    EXHIBIT 21.1

                         SUBSIDIARIES OF THE REGISTRANT

Moldflow Scandinavia (Sweden)
Moldflow International Pty. Ltd. (Australia)
Moldflow Pty. Ltd. (Australia)
Moldflow Italia s.r.l. (Italy)
Moldflow Korea Limited (Korea)
Moldflow (Europe) Ltd. (United Kingdom)
Moldflow Vertriebs GmbH (Germany)
Moldflow Japan KK (Japan)
Moldflow Singapore Pte. Ltd. (Singapore)
Moldflow France (France)
Moldflow BV (Netherlands)
Moldflow Taiwan, Inc. (Taiwan)
Moldflow Ireland, Ltd. (Ireland)
Moldflow Iberia s.l. (Spain)
Advanced CAE Technology, Inc. (New York)
Branden Technologies, Inc. (Oregon)
Moldflow Merger Corp. (Delaware)
Moldflow (Guangzhou) Ltd. (China)
Moldflow Mauritius Pty. Ltd. (Mauritius)
Moldflow Securities Corp. (Massachusetts)
American MSI Corporation LLC (Delaware)